This content is from: Home

Gaviscon maker to pay £10 million for antitrust law breach

The UK competition watchdog the Office for Fair Trading has fined Reckitt Benckiser £10.2 million ($16 million) after the company admitted abusing its dominant position when supplying heartburn medicines to the National Health Service

To access our in-house intelligence please request a trial here.

Read this article – and more – for a one-week period.

REQUEST ACCESS

Are you already an Managing IP subscriber? Login here

Instant access to all of our content. Membership Options | One Week Trial

Related